Use of Telemedicine in the Evaluation of Patients with Mast Cell Activation Syndrome

被引:0
|
作者
Kirshenbaum, Arnold [1 ]
Nichols, Chase [2 ]
Beam, Courtney [2 ]
Johnson, Carissa [2 ]
Kerrigan, Kelly [2 ]
Bundy, Elaine [2 ]
机构
[1] NIAID, NIH, LAD, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Allergy & Asthma Hlth Care, Glenn Dale, MD USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
772
引用
收藏
页码:AB237 / AB237
页数:1
相关论文
共 50 条
  • [41] Recognition and Management of Medication Excipient Reactivity in Patients With Mast Cell Activation Syndrome
    Schofield, Jill R.
    Afrin, Lawrence B.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (06): : 507 - 511
  • [42] Mast Cell Activation Syndrome in Patients with Idiopathic CD4 Lymphopenia
    Maitland, Anne
    Reed, William
    Moreau, Joanne
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 383 - 383
  • [43] Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"
    Gulen, Theo
    Akin, Cem
    Metcalfe, Dean D.
    Valent, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (04): : 1128 - 1128
  • [44] Restless legs syndrome is associated with mast cell activation syndrome
    Weinstock, Leonard B.
    Walters, Arthur S.
    Brook, Jill B.
    Kaleem, Zahid
    Afrin, Lawrence B.
    Molderings, Gerhard J.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2020, 16 (03): : 401 - 408
  • [45] Biomarkers for evaluation of mast cell and basophil activation
    Kabashima, Kenji
    Nakashima, Chisa
    Nonomura, Yumi
    Otsuka, Atsushi
    Cardamone, Chiara
    Parente, Roberta
    De Feo, Giulia
    Triggiani, Massimo
    IMMUNOLOGICAL REVIEWS, 2018, 282 (01) : 114 - 120
  • [46] Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome
    Zienkiewicz, Tomasz
    Homann, Juergen
    Muecke, Martin
    Seidel, Holger
    Hertfelder, Hans-Joerg
    Weinstock, Leonard B.
    Afrin, Lawrence B.
    Molderings, Gerhard J.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, : 268 - 274
  • [47] Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
    Butterfield, Joseph H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2542 - 2546
  • [48] Differences between patients with systemic mastocytosis (SM) and patients with Mast Cell Activation Syndrome (MCAS)
    Weiler, C.
    Alhurani, R. E.
    ALLERGY, 2016, 71 : 299 - 299
  • [49] Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome
    Hamilton, Matthew J.
    Zhao, Melissa
    Giannetti, Matthew P.
    Weller, Emily
    Hufdhi, Raied
    Novak, Peter
    Mendoza-Alvarez, Lybil B.
    Hornick, Jason
    Lyons, Jonathan J.
    Glover, Sarah C.
    Castells, Mariana C.
    Pozdnyakova, Olga
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (07) : 997 - 1004
  • [50] Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis:: Monoclonal mast cell activation syndrome
    Sonneck, Karoline
    Florian, Stefan
    Muellauer, Leonhard
    Wimazal, Friedrich
    Foedinger, Manuela
    Sperr, Wolfgang R.
    Valent, Peter
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 142 (02) : 158 - 164